Strong QoQ growth, margin at target; capacity expansion on track
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Buy
confidence 7/10
Grade B
First earnings call post-IPO; Q2 delivery aligns with stated QoQ/H1 growth rates. No prior guidance to validate.
Optimistic
next 1–2 quarters
Optimistic
multi-year
Strong sequential growth (25% revenue, 14% PAT) with margin expansion to 28% EBITDA validates operational execution. Specific FY28 target (Rs. 250 Cr) and capacity expansion roadmap (Pithampur 1.8M units by Q4, Dewas 5,500 tonnes by Q1 FY28) provide visibility. Key risk: industrial/defence segments in testing phase (6-12 months), unproven revenue contribution.
₹42.7 Cr
Revenue · +null% YoY₹8.5 Cr
Reported PAT · +51% YoYExpanding
Margins · vs guidance: CorroboratedDid the claims hold up?
Q2 revenue grew 25% sequentially
METConfirmed: Q2 revenue ₹42.67 Cr vs ₹34.14 Cr Q1 = 25.1% QoQ
PAT increased 14% sequentially
METConfirmed: Q2 PAT ₹8.5 Cr vs ₹7.46 Cr Q1 = 14.1% QoQ
EBITDA margin ~30% going forward
METQ2 EBITDA margin 28.0%, H1 margin 29.3%; in target range but not above it
Expecting revenue ~Rs. 250 crore FY28
OVERSTATEDCurrent run-rate ₹76.8 Cr H1 → ₹154 Cr annualized FY27; Rs. 250 Cr FY28 = 62% growth required
Earnings quality
What changed since the last call
Capacity roadmap crystallized
NewPithampur: 900k→1.8M units (Q4 FY27); Dewas: 3k→5.5k tonnes (Q1 FY28). First concrete capex update post-IPO.
Order book disclosed
New₹68-70 Cr order book, 78% export / 22% domestic. Provides visibility on near-term revenue.
New segment timelines
NewIndustrial shafts scale in FY28; defence in testing (6-12 months). Earlier aspirational, now specific.
The Q&A
Analysts pressed on industrial/defence revenue realization (6-12 month test cycles), working capital at scale (248-249 days), and capacity utilization (93-94% forge, 81% Pithampur). MD held firm on execution roadmap and no-fundraising need; transparent on competitive landscape but guarded on new-segment timelines.
Industrial/defence scaling — Naman Desai, Sunrise India Growth Fund
AnsweredTesting period 6-12 months; several shafts in testing now. Expect revenue ~Rs. 250 Cr FY28 across all segments.
Defence shaft specs — Prabir Adhikary, Fortune Asset Managers
AnsweredUp to 3m length, up to 47,000 newton-metres torque. Competitors: Dana, Spyker, Cummins, Neapco. Differentiation through testing and validation.
Working capital at scale — Vignesh Iyer, Sequent Investments
AnsweredCurrent cycle 248-249 days; expect improvement to 200-230 days. Can manage growth without additional funds.
Revenue/margin mix — Prithvi Bhatt, Abakkus Investment Managers
Answered64-65% components, 35-36% finished shafts. Finished shafts 5-10% higher margin. Targeting universal joints by Nov 2026 to lift margins further.
Order book composition — Prithvi Bhatt, Abakkus Investment Managers
Answered₹68-70 Cr order book; 78% export, 22% domestic. Strong geographic diversification.
International expansion — Sahil Shinde, Vaya Research
AnsweredUS and South America strongest. US subsidiary started operations; Memphis distribution centre. Targeting US, Canada, Colombia, Ecuador, Peru, Chile, Venezuela. European expansion in FY28.
Capacity utilization and FY31 vision — Prakshal Jain, Axiom Research
AnsweredForge 93-94%, Pithampur 81%. >Rs. 180 Cr FY27 target, Rs. 475-500 Cr FY31 mid-term vision with expanded platforms.
Guidance
FY27: >Rs. 180 Cr full-year
MediumImplies H2 needs ~₹103 Cr. H1 ₹77 Cr annualizes to ₹154 Cr; so >₹180 Cr needs 17% H2 acceleration.
FY28: ~Rs. 250 Cr
Medium62% growth from ₹154 Cr annualized FY27. Contingent on capacity ramp (Q4 FY27, Q1 FY28) and new-segment revenue (industrial, defence).
FY31 mid-term: Rs. 475-500 Cr
LowCAGR ~32-35% over 4 years. Assumes capacity fully utilized and new segments scaled. Aspirational; no detailed roadmap provided.
EBITDA margin: ~30% ±2pp going forward
HighSupported by disciplined procurement, manufacturing efficiency, pricing. Q2 at 28%, H1 at 29.3%; confidence in 30% level.
Finished shaft margins 5-10% higher than components
HighValue addition through assembly/balancing. Universal joints by Nov 2026 to add further uplift.
Pithampur: 900k → 1.8M units (by Q4 FY27)
HighEquipment ordered; machinery 50M Rs. purchased, 30M Rs. more on order. Phased ramp expected most operational in Q4.
Dewas: 3k → 5.5k tonnes (by Q1 FY28)
HighEquipment orders released; full ramp-up post-commissioning in Q1 FY28.
Universal joints in-house by Nov 2026
MediumCurrently procured; intent to manufacture in-house by year-end for margin improvement.
Risks the call surfaced
New-segment revenue timing
HighIndustrial and defence shafts in testing phase (6-12 months). Revenue ramp-up critical to achieve Rs. 250 Cr FY28 target. Delays would require aggressive catch-up.
Export concentration
MediumH1 FY27: 82.4% of revenue from exports, with US 59.6% of export sales. Tariffs, trade friction, or US macro slowdown pose material revenue risk.
Working capital intensity
MediumCurrent cycle 248-249 days; expected to improve to 200-230 days with India OEM mix. Inventory held in Canada/US for local shipment. Growth to Rs. 250 Cr FY28 would require significant incremental WC and capex.
Capacity ramp execution
MediumPithampur machining (900k→1.8M units by Q4 FY27) and Dewas forging (3k→5.5k tonnes by Q1 FY28) expansions critical to FY28 target. Installation, commissioning, ramp-up delays would crimp revenue.
Competitive intensity
MediumGlobal competitors (Dana, Spyker, Cummins, Neapco) in propeller shaft market. New-segment entry (industrial, defence) faces entrenched players. Pricing power and customer stickiness unproven at scale.
Management
Score 7/10. Clear and transparent on product specs, capacity roadmap, and competitive landscape. MD provided specific technical details (shaft lengths, torque specs) and names competitors. Withheld minimal detail on new-segment timelines (understandable given testing phases). IPO capital deployment on schedule (Rs. 50 Cr purchased, Rs. 30 Cr on order). Q2 delivery aligns with stated sequential and YoY growth. No prior guidance misses to judge, but track record of margin expansion (22% FY26 → 28-29% H1 FY27) supports credibility.
1 · Q4 FY27
Pithampur machining capacity doubles to 1.8M units; ramp validation
2 · Q1 FY28
Dewas forging capacity expansion (3k to 5.5k tonnes) operational
3 · Nov 2026
Universal joints in-house manufacturing completed; margin uplift target
Key risk: industrial/defence segments in testing phase (6-12 months), unproven revenue contribution.
Informational and educational content only. Not investment advice.